NASDAQ: $LNTH Understanding the Breakthrough The landscape of Alzheimer’s disease diagnosis has taken a significant step forward. The FDA has officially approved Tauklartify (florquinitau F 18), a groundbreaking diagnostic agent designed to assist healthcare professionals in evaluating patients with cognitive impairment. How It Works Tauklartify is an F 18-labeled tau positron emission tomography (PET) imaging…